http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1655467-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aed87d83b7cf793019c78cdc52a7b99 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 |
| filingDate | 1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b4fb59616b07b335466c107a3e882b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd43e4ca96635daad2ac95939ed3d23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1418e25d7d783b1d281520aa013fe33d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29ff6107a024fd8dca462cf3ab534735 |
| publicationDate | 1991-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1655467-A1 |
| titleOfInvention | Method for making differential diagnosis of prostate diseases |
| abstract | The invention relates to radiology and urology. The purpose of the invention is to improve the accuracy of the differential diagnosis of prostate cancer. A radiopaque drug myyodil and 67-Ca- (gzlli}-citrate with a total activity of 30–70 mBq) are introduced simultaneously in each prostate lobe simultaneously in 3–6 and 24–25 h after radiotherapy. Ofarm preparation, X-rays are performed immediately after the administration of the preparation, the screening data are plotted on the X-ray spectrogram, and if there are foci of reduced X-ray contrast and an increase in the intensity of the radiation 24-25 hours relative to its level A prostate cancer is diagnosed in the presence of a low radiopacity contrast center, a uniform distribution of radiation intensity after 3-6 hours and a decrease in it 24-25 hours after the drug is administered, a prostate adenoma is established, and with an increase in the size of the prostate gland, uniform contrasting and a uniform distribution of radiation intensity after 3-6 hours and a decrease in the level of radiation intensity, 24-25 hours after the administration of the drug, prostatitis is diagnosed. It is necessary to determine the X-ray picture and the distribution of radiation intensity over the prostate gland over time, which makes it possible to carry out, with an accuracy of 89%, the differential diagnosis of prostate gland diseases. (F &amp; |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2571708-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445623-C1 |
| priorityDate | 1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.